Tegmine Tx

Tegmine Therapeutics is a biotechnology company developing antibody-based therapies targeting proteins and their disease-associated glycan modifications. Its vision is to restore hope and health for patients diagnosed with incurable cancers. Significant progress has been made in cancer treatment, but much more remains to be achieved. Tegmine has developed a platform that utilizes cutting-edge mass spectrometry and CRISPR cell engineering to discover and develop higher specificity antibody-based treatments. Focusing on identifying proteins with tumor-specific modifications that drive disease progression and severity, they are advancing high-precision antibodies for the next generation of cancer therapies by targeting proteins in their pathogenic state.